Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | 03-2016 | 12-2015 | 03-2007 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -83,440 | -1,657 | 0 | N/A |
| Depreciation Amortization | 61 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 3,329 | N/A | 0 | N/A |
| Other Working Capital | 15,672 | 223 | 0 | N/A |
| Other Operating Activity | 46,163 | 1,434 | 0 | 0 |
| Operating Cash Flow | $-18,215 | $0 | $0 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -967 | N/A | 0 | N/A |
| Investing Cash Flow | $-967 | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 202,275 | N/A | 0 | N/A |
| Other Financing Activity | -2,255 | 0 | 0 | 0 |
| Financing Cash Flow | $200,020 | $N/A | $0 | $N/A |
| End Cash Position | 180,838 | N/A | 0 | N/A |
| Net Cash Flow | $180,838 | $0 | $0 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -18,215 | 0 | 0 | N/A |
| Capital Expenditure | -967 | N/A | 0 | N/A |
| Free Cash Flow | -19,182 | 0 | 0 | 0 |